(6)Applications and supplementary dossiers for the renewal of the approvals of each of these active substances were submitted in accordance with Commission Implementing Regulation (EU) 2020/1740note. On 16 August 2019, 23 May 2022, 28 January 2019, 15 March 2022, 29 July 2022, 30 March 2022, 31 May 2022, 11 October 2023, 19 March 2019, 10 August 2022 and 27 July 2022 respectively, the rapporteur Member States for 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901 and terbuthylazine informed the co-rapporteur Member States, the Commission and the European Food Safety Authority (the ‘Authority’) that they had assessed the admissibility, in particular the completeness and the timeliness, of each of these applications, and concluded that they were admissible. The supplementary dossiers for the renewal of the approval of imazalil and tefluthrin were submitted via the central submission system on 16 December 2021 and 17 February 2022, respectively and the rapporteur Member States are assessing the admissibility of the applications
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.